Deliver Your News to the World

SmallCapNewsRelease:(OTC:KKUR) To Cut Ribbon On New Facility


WEBWIRE

JERICHO, NY--(SmallCapNewsRelease)--December 16, 2009 ChromoCure, Inc (OTC:KKUR) announced today its new diagnostic research center will be opening in Aventura, Florida.

The new facility will be the hub for direct partnerships with other cancer diagnostic labs and research centers. The doors will be open in the first quarter of 2010 and be open to pathologists and researchers who wish to use ChromoCure’s technology.

ChromoCure’s technology detects the single characteristic found in every form of cancer at all stages that is never detected in normal cells. The company believes it is 100% effective and accurate in cancer detection.

To view the entire press release, visit http://finance.yahoo.com/news/ChromoCure-Inc-to-Open-New-iw-3207851833.html?x=0&.v=1

SmallCapNewsRelease gainers are Achillion Pharma (NASDAQ:ACHN) Superior Bancorp (NASDAQ:SUPR) Amarin Corp (NASDAQ:AMRN) First Bancorp Holding (NYSE:FBP) Delta Petroleum (NASDAQ:DPTR) Alliance Bankshares (NASDAQ:ABVA) Nature’s Sunshine Products (NASDAQ:NATR) Seven Arts Pictures (NASDAQ:SAPX)

SmallCapNewsRelease decliners are Helicos BioSciences Corp (NASDAQ:HLCS) PVF Capital Corp (NASDAQ:PVFC) AutoChina International (NASDAQ:AUTCW) Zion Oil & Gas (NASDAQ:ZNWAW) Retail Opportunity Investments (NASDAQ:ROICW) Cyclacel Pharma (NASDAQ:CYCC) Technitrol Inc (NYSE:TNL) EDAP TMS (NASDAQ:EDAP)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Small Cap News Release twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send no faxes or emails.



WebWireID109813




 
 KKUR
 Cancer
 Penny Stock
 Small Cap News
 Stock Tips


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.